Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Vismodegib vs PDT for Basal Cell Nevus Syndrome
NCT01556009Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Apr 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in Basal cell nevus syndrome (BCNS), sponsored by UCSF Benioff Children's Hospital Oakland. Started Apr 2012; status: completed.
02
Drugs
vismodegib
03
Conditions
Basal cell nevus syndrome (BCNS)
Beyond the preview
Go deeper on NCT01556009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556009.